Mangalam Drugs & Organics Limited (BOM:532637)
India · Delayed Price · Currency is INR 29.32
-1.13 (-3.71%)
At close: Nov 6, 2026
Mangalam Drugs & Organics Market Cap
Mangalam Drugs & Organics has a market cap or net worth of 464.08 million as of November 6, 2026. It is the 44,842nd most valuable company in the world and the 4,005th biggest in India. Its market cap has decreased by 55.60% in one year.
Market Cap
464.08M
Enterprise Value
1.36B
Revenue
2.62B
Global Rank
Country Rank
#4,005 India
PE Ratio
n/a
ChartMarket Cap Chart
Since May 24, 2005, Mangalam Drugs & Organics's market cap has increased from 214.36M to 464.08M, an increase of 116.49%. That is a compound annual growth rate of 3.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 464.08M | 6.27% |
| Dec 31, 2025 | 436.70M | -76.09% |
| Dec 31, 2024 | 1.83B | 17.53% |
| Dec 29, 2023 | 1.55B | -28.41% |
| Dec 30, 2022 | 2.17B | 5.87% |
| Dec 31, 2021 | 2.05B | -7.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Onyx Biotec | 652.76M |
| Rekvina Laboratories | 633.49M |
| Phaarmasia | 565.55M |
| ANG Lifesciences India | 486.55M |
| Biofil Chemicals and Pharmaceuticals | 470.80M |
| Vista Pharmaceuticals | 381.01M |
| Rajnish Wellness | 365.53M |
| JFL Life Sciences | 354.70M |